LYNK Pharmaceuticals Funding: $50M Raised, Series B (2021)
LYNK Pharmaceuticals is based in Hangzhou, China. It has raised $50M in total funding. Latest round: Series B.
LYNK Pharmaceuticals funding overview
LYNK Pharmaceuticals is based in Hangzhou, China. LYNK Pharmaceuticals has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2021. The round record for LYNK Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Lilly Asia Ventures, New Alliance Capital, Hangzhou HEDA Biological Medicine Venture Capital Partnersh…, Legend Capital, Med-Fine Capital. 5 distinct backers are named across the disclosed rounds.
LYNK Pharmaceuticals at a glance
Total raised
$50M
Latest round
Series B
Latest round date
August 2021
Headquarters
Hangzhou, China
Notable investors
Lilly Asia Ventures, New Alliance Capital, Hangzhou HEDA Biological Medicine Venture Capital Partnersh…, Legend Capital, Med-Fine Capital
Frequently asked about LYNK Pharmaceuticals funding
How much has LYNK Pharmaceuticals raised?
LYNK Pharmaceuticals has raised $50M in total disclosed funding across the rounds on record.
Who has invested in LYNK Pharmaceuticals?
Lilly Asia Ventures, New Alliance Capital, Hangzhou HEDA Biological Medicine Venture Capital Partnersh…, Legend Capital, Med-Fine Capital are named among the investors backing LYNK Pharmaceuticals.
What was the latest LYNK Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in August 2021.
Where is LYNK Pharmaceuticals based?
LYNK Pharmaceuticals is based in Hangzhou, China.
When did LYNK Pharmaceuticals last raise?
The last disclosed LYNK Pharmaceuticals round closed in August 2021 at Series B.
Every LYNK Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Hangzhou at a similar stage.
